NervGen Pharma Corp - Ordinary Shares

(OTO:NRVNF)

Symbol has changed to a new ticker symbol

(NGENF)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

NervGen Pharma Corp is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nerve injuries. The company is advancing a drug candidate called NVG-291 initially for the treatment of spinal cord injury while exploiting its technologies to identify additional therapeutic candidates for other related medical conditions. Its technology targets protein tyrosine phosphatase sigma, a neural receptor that impedes nerve regeneration.

Contact Information

Website: www.nervgenpharma.com
Main Phone: +1 604 722-5361
Address: 595 Burrard Street
Address 2: Suite 1703, Three Bentall Centre
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V7X 1J1

Issuer Information

Exchange: OTO
CEO: Ernest Shingyan Wong
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A